The Canada HRT market size stood at around USD XX billion in 2019 and is projected to reach USD XX billion by 2028, exhibiting a CAGR of XX% during the forecast period.
For many years, women have been prescribed Estrogen with or without Progestin Hormone Replacement Therapy (HRT) to relieve some of the symptoms of menopause. However, recent scientific studies have identified significant risks associated with this therapy. Health Canada has approved HRT products to treat menopausal symptoms such as hot flashes, night sweats, and in some cases, to prevent osteoporosis. While other forms of hormone replacement are available, such as the patch and gel, HRT is most commonly taken in pill form.
The significant factors that contribute toward the growth of the hormone replacement therapy market include a rise in the prevalence of menopausal disorder and an increase in awareness about post-menopausal issues among women. New launches of hormone replacement therapy are expected to contribute to the hormone replacement therapy market growth notably. However, adverse effects of hormone replacement therapy and the high cost of treatment are anticipated to hamper the market growth during the forecast period. On the contrary, the introduction of bioidentical hormone replacement therapy and leveraging telemedicine for hormone replacement therapy are expected to provide the remunerative opportunity to expand the hormone replacement therapy market.